In addition, it is known that ANGTPL2, also regulated by TGF-β, has an inflammatory and fibrogenic potential [52] and that suppression of SMOC2 ameliorates kidney, pulmonary, and liver fibrosis [54,55,56]. Here, SMOC2 is linked to Hepatic fibrosis.